SEGMENT REPORTING (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total Assets	$ 32,170,384		$ 32,170,384
Total Liabilities	4,565,114		4,565,114
Total Assets	32,305,137		32,305,137		$ 13,118,821
Total Liabilities	4,699,867		4,699,867		3,364,065
Revenues	3,551,565	$ 1,560,633	7,748,499	$ 4,727,631
Net Sales	3,551,564	1,560,633	7,748,499	4,727,631
Cost of Goods Sold	2,500,163	1,482,455	5,231,155	3,825,037
Research and development	0	65,037	53,408	65,037
Stock based compensation expense			1,102,609	381,314
Stock based compensation	426,268	279,707	1,102,609	381,314
Selling, General and Administrative Expenses	2,256,757	624,228	5,888,863	1,443,276
Hospitality Segment [Member]
Segment Reporting Information [Line Items]
Total Assets	2,309,410		2,309,410
Total Liabilities	2,642,754		2,642,754
Total Assets					12,655,779
Total Liabilities					2,721,396
Revenues	1,750,227	1,560,633	4,282,696	4,727,631
Cost of goods sold	1,451,560	1,482,455	3,269,335	3,825,037
Research and development
Stock based compensation expense	216,568	141,791	559,698	192,594
Selling, General and Administrative Expenses	571,605	604,597	1,791,835	1,371,531
Disinfectant Segment [Member]
Segment Reporting Information [Line Items]
Total Assets	16,502,516		16,502,516
Total Liabilities	1,627,721		1,627,721
Total Assets					463,042
Total Liabilities					642,669
Revenues	1,801,337		3,465,803
Cost of goods sold	1,048,603		1,961,820
Research and development		65,037	53,408	65,037
Stock based compensation expense	209,700	137,916	542,911	188,720
Selling, General and Administrative Expenses	1,685,152	$ 19,631	4,097,028	$ 71,745
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Total Assets	13,358,458		13,358,458
Total Liabilities	$ 294,639		$ 294,639
Total Assets
Total Liabilities